Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 4 minute read Pharma Industry News Suven life sciences reports rapid-acting depression treatment breakthrough with ropanicant in phase-2a trial Suven Life Sciences’ Ropanicant delivers rapid antidepressant effects in Phase-2a trial for MDD. See the results, safety profile, and what’s next. byPallavi MadhirajuSeptember 19, 2024